Abstract
Juvenile polyps are a common finding in the pediatric population. In contrast, colon adenomas, which are viewed as dysplastic precancerous lesions, are found sporadically in late adulthood. Adenomas in children and young adults are highly unusual and suggest one of several forms of inherited colorectal cancer. These disorders show a predilection to early adenoma formation and can present in childhood. Familial adenomatous polyposis and Lynch syndrome are autosomal dominant, often with involvement of multiple family members, or can be seen in an individual arising from a de novo mutation. The most recently described adenomatous polyposis syndrome, MutYH-associated polyposis, is autosomal recessive, requiring an inherited mutation from each parent. All three adenomatous polyposis disorders can display tremendous variation in expression, even within the same family, and can have a common overlapping phenotype. These disorders require regular medical care to minimize cancer risk in the digestive tract and in other organ systems.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Itzkowitz SH, Rochester J: Colonic polyps and polyposis syndromes. In Sleisenger & Fordtran’s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management, edn 8. Edited by Feldman M, Friedman LS, Brandt LJ. Philadelphia: WB Saunders; 2006:2720–2725.
Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999, 116:1453–1456.
Lynch HT, Boland CR, Gong G, et al.: Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 2006, 14:390–402.
Boland CR, Thibodeau SN, Hamilton SR, et al.: A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998, 58:5248–5257.
Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261–268.
Jass JR: Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term. World J Gastroenterol 2006, 12:4943–4950.
Lindor NM, Rabe K, Peterson G, et al.: Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 2005, 293:1979–1985.
Mueller-Koch Y, Vogelsang H, Lohse P, et al.: Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005, 54:1733–1740.
Huang SC, Lavine JE, Boland PS, et al.: Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr 2001, 138:629–635.
Durno C, Aronson M, Bapat B, et al.: Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 2005, 54:1146–1150.
Muller A, Schackert HK, Lange B, et al.: A novel MSH2 germline mutation in homozygous state in two brothers with colorectal cancers diagnosed at the age of 11 and 12 years. Am J Med Genet 2006, 140A:195–199.
Gallinger S, Aronson M, Shayan K, et al.: Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 2004, 126:576–585.
Kraus C, Kastl S, Gunther K, et al.: A proven de novo germline mutation in HNPCC. J Med Genet 1999, 36:919–921.
de Jong AE, Hendriks YM, Kleibeuker JH, et al.: Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006 130:665–671.
National Comprehensive Cancer Network: v.1.2006 Clinical Practice Guidelines in Oncology—Colorectal Cancer Screening. http://www.nccn.org/professional/physician_gls/PDF/colorectal_screening.pdf. Accessed January 11, 2007.
Lindor NM, Petersen GM, Hadley DW, et al.: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006, 296:1507–1517.
Hendriks YM, de Jong AE, Morreau H, et al.: Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin 2006, 56:213–225.
Solomon C, Burt RW: APC-associated polyposis conditions. GeneReviews http://www.genetests.org. Accessed January 11, 2007.
Auricchio R, De Rosa M, Quaglietta L, et al.: A dramatic case of early-onset familial adenomatous polyposis. Clin Genet 2005, 67:104–106.
Galiatsatos P, Foulkes WD: Familial adenomatous polyposis Am J Gastroenterol. 2006, 101:385–398.
Akiyama T, Kawasaki Y: Wnt signaling and the actin cytoskeleton. Oncogene 2006, 25:7538–7544.
Dikovskaya D, Schiffmann D, Newton IP, et al.: Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol 2007, 176:183–195.
Grady WM, Markowitz SD: Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 2002, 3:101–128.
Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759–767.
Trimbath JB, Giardiello FM: Genetic testing and counseling for hereditary colorectal cancer [review]. Aliment Pharmacol Ther 2002, 16:1843–1857.
Bussey HJR: Relationship to carcinoma. In Familial Polyposis Coli: Family Studies, Histopathology, Differential Diagnosis, and Results of Treatment. Baltimore: The Johns Hopkins University Press; 1975:47–50.
Iwama T, Tamura K, Morita T, et al.: A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 2004, 9:308–316.
Friedl W, Caspari R, Sengteller M, et al.: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families. Gut 2001, 48:515–521.
Bülow S: Results of national registration of familial adenomatous polyposis. Gut 2003, 52:742–746.
Church JM, McGannon E, Burke C, Clark B: Teenagers with familial adenomatous polyposis: what is their risk for colorectal cancer? Dis Colon Rectum 2002, 45:887–889.
Debinski HS, Love S, Spigelman AD, et al.: Colorectal polyp counts and cancer risk in familial adenomatous polyposis. Gastroenterology 1996, 110:1028–1030.
Brosens LA, Keller JJ, Offerhaus GJ, et al.: Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut 2005, 54:1034–1043.
Galle TS, Juel K, Bulow S: Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 1999, 34:808–812.
Attard TM, Cuffari C, Tajouri T, et al.: Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol 2004, 99:681–686.
Morpurgo E, Vitale GC, Galandiuk S, et al.: Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas. J Gastrointest Surg 2004, 8:559–564.
Hirschman BA, Pollock BH, Tomlinson GE: The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds. J Pediatr 2005, 147:263–266.
Durno CA, Gallinger S: Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. J Pediatr Gastroenterol Nutr 2006, 43:5–15.
Wu JS, Paul P, McGannon EA, Church JM: APC genotype, polyp number, and surgical options in familial adenomatous polyposis. Ann Surg 1998, 227:57–62.
Bülow C, Vasen H, Jarvinen H, et al.: Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterology 2000, 119:1454–1460.
Church J: Ileoanal pouch neoplasia in familial adenomatous polyposis: an underestimated threat. Dis Colon Rectum 2005, 48:1708–1713.
Al-Tassan N, Chmiel NH, Maynard J, et al.: Inherited variants of MYH associated with somatic G:C→T: A mutations in colorectal tumors. Nat Gene 2002, 30:227–232.
Sampson JR, Jones S, Dolwani S, Cheadle JP: MutYH (MYH) and colorectal cancer. Biochem Soc Trans 2005, 33:679–683.
Aretz S, Uhlhaas S, Goergens H, et al.: MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer 2006, 119, 807–814.
Sampson JR, Dolwani S, Jones S, et al.: Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003, 362:39–41.
Croitoru ME, Cleary SP, Nando Di Nicola N, et al.: Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. J Natl Cancer Inst 2004, 96:1631–1634.
Ponti G, Ponz de Leona M, Maffeia S, et al.: Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. Clin Genet 2005, 68:442–447.
Jo WS, Bandipalliam P, Shannon KM, et al.: Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol 2005, 3:1022–1028.
Farrington SM, Tenesa A, Barnetson R et al.: Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 2005, 77:112–119.
Webb EL, Rudd MF, Houlston RS: Colorectal cancer risk in monoallelic carriers of MYH variants [letter]. Am J Hum Genet 2006, 8:771.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erdman, S.H. Pediatric adenomatous polyposis syndromes: An update. Curr Gastroenterol Rep 9, 237–244 (2007). https://doi.org/10.1007/s11894-007-0025-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11894-007-0025-0